Point72 Hong Kong LTD Lannett CO Inc Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.17 - $5.74 $20,854 - $28,705	-5,001 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.28 - $9.64 $26,405 - $48,209	5,001 New	5,001 $26,000
Q4 2019 Feb 14, 2020	SELL	$8.49 - $12.81 $33,968 - $51,252	-4,001 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.58 - $14.47 $9,815 - $25,452	1,759 Added 78.46%	4,001 $45,000
Q2 2019 Aug 14, 2019	BUY	$5.22 - $9.08 $11,703 - $20,357	2,242 New	2,242 $14,000
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $1,353 - $4,132	-285 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.45 $3,790 - $4,973	285 New	285 $4,000
Q4 2017 Feb 14, 2018	SELL	$19.9 - $29.25 $83,261 - $122,382	-4,184 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.1 - $19.25 $63,178 - $80,542	4,184	4,184 $77,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.